{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T20:45:58Z","timestamp":1780778758998,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T00:00:00Z","timestamp":1736640000000},"content-version":"am","delay-in-days":286,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U18DA052559"],"award-info":[{"award-number":["U18DA052559"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.pnpbp.2024.110941","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T20:22:35Z","timestamp":1704745355000},"page":"110941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Small molecule NOP agonists reverse locomotor sensitization induced by cocaine in male C57BL\/6 mice"],"prefix":"10.1016","volume":"131","author":[{"given":"Kabirullah","family":"Lutfy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurulain T.","family":"Zaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pnpbp.2024.110941_bb0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.biopsych.2010.02.010","article-title":"Orphanin FQ\/nociceptin not only blocks but also reverses behavioral adaptive changes induced by repeated cocaine in mice","volume":"68","author":"Bebawy","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2024.110941_bb0010","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1007\/s11606-019-05074-8","article-title":"Pharmacotherapy for cocaine use disorder-a systematic review and Meta-analysis","volume":"34","author":"Chan","year":"2019","journal-title":"J. Gen. Intern. Med."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.110941_bb0015","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12844","article-title":"Potent and selective NOP receptor activation reduces cocaine self-administration in rats by lowering hedonic set point","volume":"25","author":"Cippitelli","year":"2020","journal-title":"Addict. Biol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110941_bb0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/026988119801200107","article-title":"A role for sensitization in craving and relapse in cocaine addiction","volume":"12","author":"Kalivas","year":"1998","journal-title":"J. Psychopharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2024.110941_bb0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2008.07.011","article-title":"Glutamate transmission in addiction","volume":"56","author":"Kalivas","year":"2009","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110941_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuron.2004.09.016","article-title":"Memory and addiction: shared neural circuitry and molecular mechanisms","volume":"44","author":"Kelley","year":"2004","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110941_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00213-002-1192-1","article-title":"Orphanin FQ\/nociceptin blocks cocaine-induced behavioral sensitization in rats","volume":"164","author":"Lutfy","year":"2002","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110941_bb0040","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuropharm.2008.05.010","article-title":"Alterations in the level of OFQ\/N-IR in rat brain regions by cocaine","volume":"55","author":"Lutfy","year":"2008","journal-title":"Neuropharmacology"},{"issue":"33","key":"10.1016\/j.pnpbp.2024.110941_bb0045","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.2174\/092986712803988893","article-title":"Side effects of cocaine abuse: multiorgan toxicity and pathological consequences","volume":"19","author":"Riezzo","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110941_bb0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","article-title":"Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis","volume":"396","author":"Robinson","year":"1986","journal-title":"Brain Res."},{"issue":"Suppl. 2","key":"10.1016\/j.pnpbp.2024.110941_bb0055","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1046\/j.1360-0443.95.8s2.19.x","article-title":"The psychology and neurobiology of addiction: an incentive-sensitization view","volume":"95","author":"Robinson","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2024.110941_bb0060","first-page":"247","article-title":"Behavioral and neurochemical correlates of repeated d-amphetamine administration","volume":"13","author":"Segal","year":"1975","journal-title":"Adv. Biochem. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110941_bb0065","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/bjp.2008.77","article-title":"Neuroplasticity in the mesolimbic dopamine system and cocaine addiction","volume":"154","author":"Thomas","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110941_bb0070","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.109.157446","article-title":"Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor\/mu-opioid receptor ligands: implications for therapeutic applications","volume":"331","author":"Toll","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2024.110941_bb0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130000493","article-title":"Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies","volume":"151","author":"Vanderschuren","year":"2000","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110941_bb0080","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0006-8993(93)91761-G","article-title":"Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat","volume":"605","author":"Vezina","year":"1993","journal-title":"Brain Res."},{"issue":"15","key":"10.1016\/j.pnpbp.2024.110941_bb0085","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1021\/acs.jmedchem.5b01499","article-title":"Nociceptin opioid receptor (NOP) as a therapeutic target: Progress in translation from preclinical research to clinical utility","volume":"59","author":"Zaveri","year":"2016","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.pnpbp.2024.110941_bb0090","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1021\/jm034249d","article-title":"A novel series of piperidin-4-yl-1,3-dihydroindol-2-ones as agonist and antagonist ligands at the nociceptin receptor","volume":"47","author":"Zaveri","year":"2004","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.110941_bb0095","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1016\/j.bmcl.2013.03.101","article-title":"Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP receptor-selective scaffolds","volume":"23","author":"Zaveri","year":"2013","journal-title":"Part I. Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110941_bb0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/acer.13575","article-title":"A novel and selective Nociceptin receptor (NOP) agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) decreases Acquisition of Ethanol-Induced Conditioned Place Preference in mice","volume":"42","author":"Zaveri","year":"2018","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.pnpbp.2024.110941_bb0105","first-page":"638","article-title":"The Nociceptin receptor (NOP) agonist AT-312 blocks Acquisition of Morphine- and Cocaine-Induced Conditioned Place Preference in mice","volume":"9","author":"Zaveri","year":"2018","journal-title":"Front. Psychol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624000095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624000095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:03:48Z","timestamp":1759521828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624000095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":21,"alternative-id":["S0278584624000095"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.110941","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small molecule NOP agonists reverse locomotor sensitization induced by cocaine in male C57BL\/6 mice","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.110941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110941"}}